Constitutive androstane receptor

From WikiMD's WELLNESSPEDIA

Constitutive androstane receptor (CAR) is a member of the nuclear receptor family of intracellular transcription factors. It is primarily known for its role in the regulation of xenobiotic metabolism and the body's response to foreign substances.

Function[edit]

CAR is a key regulator of xenobiotic-induced transcription of phase I (cytochrome P450s), phase II (conjugation) and phase III (transporter) genes in the liver. It is activated by a variety of endogenous and exogenous chemicals, including many drugs and environmental pollutants. Once activated, CAR translocates to the nucleus, where it binds to specific DNA sequences and regulates the transcription of target genes.

Structure[edit]

CAR is a protein that is encoded by the NR1I3 gene in humans. It consists of several domains, including a DNA-binding domain and a ligand-binding domain. The DNA-binding domain allows CAR to bind to specific DNA sequences, while the ligand-binding domain allows it to interact with various ligands.

Clinical significance[edit]

CAR plays a crucial role in drug metabolism and detoxification. It is involved in the metabolism of many drugs, including phenobarbital, rifampicin, and carbamazepine. Alterations in CAR function can affect drug efficacy and toxicity. In addition, CAR is implicated in several diseases, including diabetes, obesity, and cancer.

Research[edit]

Research on CAR has focused on its role in drug metabolism and disease. Studies have shown that CAR activation can induce drug metabolism and detoxification, protect against chemical-induced liver injury, and regulate energy homeostasis. In addition, CAR has been implicated in the development and progression of several types of cancer, including liver and lung cancer.

See also[edit]

This article is a stub related to biology. You can help WikiMD by expanding it!



Constitutive androstane receptor[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.